September 25, 2026

Butterfly Network, Inc. (BFLY) Investor Outlook: A 11.58% Upside Potential Amid Strong Revenue Growth

Butterfly Network, Inc. (BFLY), a pioneer in the healthcare sector, is making waves in the medical devices industry with its innovative ultrasound imaging solutions. With a..

KalVista Pharmaceuticals, Inc. (KALV) Stock Analysis: Evaluating a Steady Valuation in the Biotech Space

KalVista Pharmaceuticals, Inc. (KALV), a biopharmaceutical company specializing in the development of oral therapies for rare diseases, has carved out a niche within the biotechnology sector...

Taysha Gene Therapies, Inc. (TSHA): Potential 171% Upside as Analysts Rally Behind This Biotech Innovator

Taysha Gene Therapies, Inc. (NASDAQ: TSHA) is making waves in the biotechnology sector with its ambitious focus on developing gene therapies for severe monogenic diseases of..

Collegium Pharmaceutical, Inc. (COLL) Stock Analysis: Evaluating a 116% Potential Upside

Collegium Pharmaceutical, Inc. (NASDAQ: COLL), a prominent player in the healthcare sector specializing in pain management pharmaceuticals, is capturing investor attention with its remarkable potential upside...

CorMedix Inc. (CRMD) Stock Analysis: A 97% Potential Upside with Strong Analyst Consensus

CorMedix Inc. (NASDAQ: CRMD) stands out in the biotechnology sector with a remarkable potential upside of 97.34%, according to analyst ratings. This intriguing figure is further..

Altimmune, Inc. (ALT) Stock Analysis: Uncovering a 462.87% Potential Upside in Biotechnology

Altimmune, Inc. (NASDAQ: ALT) is making significant waves in the biotechnology sector with its groundbreaking work in developing therapies for serious liver diseases. This Gaithersburg, Maryland-based..

RxSight, Inc. (RXST) Stock Analysis: Exploring a Potential 60% Upside for Investors

RxSight, Inc. (NASDAQ: RXST), a healthcare company specializing in medical devices, particularly those used in cataract surgery, is capturing investor attention with its innovative approach in..

Castle Biosciences (CSTL): Investor Outlook Reveals 28% Potential Upside

Castle Biosciences, Inc. (NASDAQ: CSTL), a prominent player in the healthcare sector, is garnering attention from investors due to its innovative solutions in the diagnostics and..

Arbutus Biopharma Corporation (ABUS): Investor Outlook on Growth Potential and Analyst Ratings

Arbutus Biopharma Corporation (NASDAQ: ABUS) stands out in the biotechnology sector with its focus on developing novel therapeutics for infectious diseases, notably chronic Hepatitis B virus..

AxoGen, Inc. (AXGN) Stock Analysis: Exploring a Potential 24% Upside in the Healthcare Sector

AxoGen, Inc. (NASDAQ: AXGN) has emerged as a compelling player in the healthcare sector, particularly in the medical devices industry. Specializing in peripheral nerve regeneration and..

Delcath Systems, Inc. (DCTH) Stock Analysis: Exploring 49% Potential Upside in the Medical Device Sector

Investors seeking opportunities in the healthcare sector may find Delcath Systems, Inc. (NASDAQ: DCTH) a compelling prospect. The company, which specializes in interventional oncology, primarily focuses..

REGENXBIO Inc. (RGNX) Stock Analysis: Unveiling a 227% Potential Upside in the Biotech Sector

REGENXBIO Inc. (NASDAQ: RGNX), a clinical-stage biotechnology company based in Rockville, Maryland, is garnering significant attention from investors due to its promising advancements in gene therapy..

STAAR Surgical Company (STAA)

⚠️ No article content returned.

..

Spyre Therapeutics, Inc. (SYRE): Analyst Ratings Point to a Potential 37.88% Upside in Biotech

In the competitive landscape of biotechnology, Spyre Therapeutics, Inc. (NASDAQ: SYRE) stands out not just for its cutting-edge research in inflammatory bowel and rheumatic diseases but..

Dianthus Therapeutics, Inc. (DNTH) Stock Report: Analysts Predict a 55% Upside Potential

Dianthus Therapeutics, Inc. (DNTH) is making waves in the biotechnology industry with its promising pipeline of therapies aimed at severe autoimmune diseases. As a clinical-stage biotechnology..

InMode Ltd. (INMD) Stock Analysis: Exploring a 13.93% Upside Potential in the Medical Devices Sector

InMode Ltd. (NASDAQ: INMD), a prominent player in the healthcare sector with a focus on medical devices, offers a compelling opportunity for investors seeking exposure to..

Vir Biotechnology, Inc. (VIR) Stock Analysis: A 93.82% Upside Potential Amidst Robust Revenue Growth

Vir Biotechnology, Inc. (NASDAQ: VIR), a prominent player in the biotechnology sector, has captured investor attention with a substantial upside potential of 93.82%. This clinical-stage biopharmaceutical..

Eton Pharmaceuticals, Inc. (ETON) Stock Report: Eyeing a 19.35% Upside with Robust Revenue Growth

Eton Pharmaceuticals, Inc. (NASDAQ: ETON) stands out in the healthcare sector, specifically within the niche of specialty and generic drug manufacturing. With a current market cap..

Iovance Biotherapeutics, Inc. (IOVA) Stock Analysis: Navigating the Biotech Frontier with Strong Revenue Growth

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) is making waves in the biotechnology sector, a space known for its volatility but also its potential for groundbreaking advancements. With..

Maravai LifeSciences Holdings (MRVI) Stock Analysis: Navigating Growth in the Biotechnology Sector

Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI), a prominent player in the biotechnology industry, is capturing investor attention with its strategic focus on enabling the development of..

Search

Funds

September 25, 2026

Search

Funds

September 25, 2026

FTSE 100

Funds